The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Oxidative stress and atherosclerosis
Open accessAbstract
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the Western world. Its incidence has been increasing lately in developing countries. Several lines of evidence support a role for oxidative stress in atherogenesis. Growing evidence indicates that chronic and acute overproduction of reactive oxygen species (ROS) under pathophysiologic conditions is integral in the development of cardiovascular diseases (CVD). ROS mediate various signaling pathways that underlie vascular inflammation in atherogenesis from the initiation of fatty streak development through lesion progression to ultimate plaque rupture. Various animal models of oxidative stress support the notion that ROS have a causal role in atherosclerosis and other cardiovascular diseases. Human investigations also support the oxidative stress hypothesis of atherosclerosis. Oxidative stress is the unifying mechanism for many CVD risk factors, which additionally supports its central role in CVD. A main source of ROS in vascular cells is the reduced nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase system. This is a membrane-associated enzyme, composed of five subunits, catalyzing the one-electron reduction of oxygen, using NADH or NADPH as the electron donor. This system is an important target for genetic investigations. Identification of groups of patients with genetically prone or resistant of oxidative stress is therefore an obvious target of investigation. A better understanding of the complexity of cellular redox reactions, development of a new class of antioxidants targeted to specific subcellular sites, and the phenotype-genotype linkage analysis for oxidative stress will likely be avenues for future research with regards to the broader use of pharmacological therapies in the treatment and prevention of CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. W. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,793
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Oxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618 · cited 2×
“[4] N.”
BackgroundMorrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,339
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Role of oxidative stress in atherosclerosis
Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., & Drexler, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03144-2 · Cited by 1,275
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,187
Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P., & Ganz, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320802 · Cited by 1,109
Boaz, M., Smetana, S., Weinstein, T., Matas, Z., Gafter, U., Iaina, A., Knecht, A., Weissgarten, Y., Brunner, D., Fainaru, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02783-5 · Cited by 1,025
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Vitamin C exhibits pro-oxidant properties
Podmore, I. D., Griffiths, H. R., Herbert, K. E., Mistry, N., Mistry, P., & Lunec, J. (1998) · Nature · doi:10.1038/33308 · Cited by 800
Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742
Zheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Laursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721
Role of ubiquinone in the mitochondrial generation of hydrogen peroxide
Boveris, A., Cadenas, E., & Stoppani, A. O. M. (1976) · Biochemical Journal · doi:10.1042/bj1560435 · Cited by 655
Stolk, J., Hiltermann, T. J., Dijkman, J. H., & Verhoeven, A. J. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.1.8018341 · Cited by 648
Miller, F. J., Gutterman, D. D., Rios, C. D., Heistad, D. D., & Davidson, B. L. (1998) · Circulation Research · doi:10.1161/01.res.82.12.1298 · Cited by 623
Targeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1132 · Cited by 585
Peripheral Arterial Disease in Patients With Diabetes
Marso, S. P., & Hiatt, W. R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.065 · Cited by 575
VITAMIN E, OXIDATIVE STRESS, AND INFLAMMATION
Singh, U., Devaraj, S., & Jialal, I. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132446 · Cited by 575
Self-citationLipid advanced glycosylation: pathway for lipid oxidation in vivo.
Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., & Vlassara, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6434 · Cited by 571
C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
Jialal, I., Devaraj, S., & Venugopal, S. K. (2004) · Hypertension · doi:10.1161/01.hyp.0000130484.20501.df · Cited by 568
Self-citationPlatelet Activation in Obese Women: Role of Inflammation and Oxidant Stress
Davì, G., Guagnano, M. T., Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., Nutini, M., Sensi, S., & Patrono, C. (2002) · JAMA · doi:10.1001/jama.288.16.2008 · Cited by 541
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
How hyperglycemia promotes atherosclerosis: molecular mechanisms
Aronson, D., & Rayfield, E. J. (2002) · Cardiovascular Diabetology · doi:10.1186/1475-2840-1-1 · Cited by 504
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
Lentz, S. R., Sobey, C. G., Piegors, D. J., Bhopatkar, M. Y., Faraci, F. M., Malinow, M. R., & Heistad, D. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118771 · Cited by 501
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 492
Mitochondrial Integrity and Function in Atherogenesis
Ballinger, S. W., Patterson, C., Knight-Lozano, C. A., Burow, D. L., Conklin, C. A., Hu, Z., Reuf, J., Horaist, C., Lebovitz, R., Hunter, G. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000023921.93743.89 · Cited by 478
Frei, B., Forte, T. M., Ames, B. N., & Cross, C. E. (1991) · Biochemical Journal · doi:10.1042/bj2770133 · Cited by 471
Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
Patrono, C., & FitzGerald, G. A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2309 · Cited by 453 · cited 2×
“F2-isoprostanes, rostaglandin-like products of the free radical-catalyzed perxidation of arachidonic acid and an established biomarker of n vivo lipid peroxidation [9–11], have been found to localize n foam cells in atherosclerotic lesions of humans [12,13] as ell as animals and are significantly increased in the tiss…”
BackgroundTRANSCRIPTION OF THE MAMMALIAN MITOCHONDRIAL GENOME
Clayton, D. A. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.003041 · Cited by 448
Ballinger, S. W., Patterson, C., Yan, C.-N., Doan, R., Burow, D. L., Young, C. G., Yakes, F. M., Van Houten, B., Ballinger, C. A., Freeman, B. A., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.9.960 · Cited by 442
Mackness, B., Davies, G. K., Turkie, W., Lee, E., Roberts, D. H., Hill, E., Roberts, C., Durrington, P. N., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.094247 · Cited by 435
Zhang, R., Brennan, M.-L., Shen, Z., MacPherson, J. C., Schmitt, D., Molenda, C. E., & Hazen, S. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209124200 · Cited by 432
Heitzer, T., Krohn, K., Albers, S., & Meinertz, T. (2000) · Diabetologia · doi:10.1007/s001250051551 · Cited by 427
Shih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 425
Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease
Austin, R. C., Lentz, S. R., & Werstuck, G. H. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401451 · Cited by 414
Mügge, A., Elwell, J. H., Peterson, T. E., Hofmeyer, T. G., Heistad, D. D., & Harrison, D. G. (1991) · Circulation Research · doi:10.1161/01.res.69.5.1293 · Cited by 399
Salonen, R. M., Nyyssönen, K., Kaikkonen, J., Porkkala-Sarataho, E., Voutilainen, S., Rissanen, T. H., Tuomainen, T.-P., Valkonen, V.-P., Ristonmaa, U., Lakka, H.-M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000050626.25057.51 · Cited by 382
Tummala, P. E., Chen, X.-L., Sundell, C. L., Laursen, J. B., Hammes, C. P., Alexander, R. W., Harrison, D. G., & Medford, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1223 · Cited by 379
Progress Towards the Discovery of Xanthine Oxidase Inhibitors
Borges, F., Fernandes, E., & Roleira, F. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023371229 · Cited by 372
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Vita, J. A., Brennan, M.-L., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor, M. H., Penn, M. S., Keaney, J. F., & Hazen, S. L. (2004) · Circulation · doi:10.1161/01.cir.0000140262.20831.8f · Cited by 365
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119735 · Cited by 344
Increased atherosclerosis in myeloperoxidase-deficient mice
Brennan, M.-L., Anderson, M. M., Shih, D. M., Qu, X.-D., Wang, X., Mehta, A. C., Lim, L. L., Shi, W., Hazen, S. L., Jacob, J. S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci8797 · Cited by 323
Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes
Tan, K. C. B., Chow, W.-S., Ai, V. H. G., Metz, C., Bucala, R., & Lam, K. S. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1055 · Cited by 319
Ascorbate Restores Endothelium-Dependent Vasodilation Impaired by Acute Hyperglycemia in Humans
Beckman, J. A., Goldfine, A. B., Gordon, M. B., & Creager, M. A. (2001) · Circulation · doi:10.1161/01.cir.103.12.1618 · Cited by 318
Knowles, J. W., Reddick, R. L., Jennette, J. C., Shesely, E. G., Smithies, O., & Maeda, N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8376 · Cited by 305
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect
Inoue, I., Goto, S.-I., Mizotani, K., Awata, T., Mastunaga, T., Kawai, S.-I., Nakajima, T., Hokari, S., Komoda, T., & Katayama, S. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00680-9 · Cited by 298
Spiekermann, S., Landmesser, U., Dikalov, S., Bredt, M., Gamez, G., Tatge, H., Reepschläger, N., Hornig, B., Drexler, H., & Harrison, D. G. (2003) · Circulation · doi:10.1161/01.cir.0000056762.69302.46 · Cited by 298
Jialal, I., & Grundy, S. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41515-9 · Cited by 295
Self-citationFang, J. C., Kinlay, S., Beltrame, J., Hikiti, H., Wainstein, M., Behrendt, D., Suh, J., Frei, B., Mudge, G. H., Selwyn, A. P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08154-0 · Cited by 293
Rozenberg, O. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01429-6 · Cited by 282
Myeloperoxidase and its contributory role in inflammatory vascular disease
Lau, D., & Baldus, S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.023 · Cited by 277
Ungvari, Z., Csiszar, A., Edwards, J. G., Kaminski, P. M., Wolin, M. S., Kaley, G., & Koller, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000061735.85377.40 · Cited by 267
Rueckschloss, U., Galle, J., Holtz, J., Zerkowski, H.-R., & Morawietz, H. (2001) · Circulation · doi:10.1161/hc4001.097056 · Cited by 252
Kuhlencordt, P. J., Chen, J., Han, F., Astern, J., & Huang, P. L. (2001) · Circulation · doi:10.1161/01.cir.103.25.3099 · Cited by 251
Malle, E., Waeg, G., Schreiber, R., Gröne, E. F., Sattler, W., & Gröne, H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01498.x · Cited by 245
Pagano, P. J., Chanock, S. J., Siwik, D. A., Colucci, W. S., & Clark, J. K. (1998) · Hypertension · doi:10.1161/01.hyp.32.2.331 · Cited by 229
Pieper, G. M. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199701000-00002 · Cited by 224
Knight-Lozano, C. A., Young, C. G., Burow, D. L., Hu, Z. Y., Uyeminami, D., Pinkerton, K. E., Ischiropoulos, H., & Ballinger, S. W. (2002) · Circulation · doi:10.1161/hc0702.103977 · Cited by 217
Vascular smooth muscle cell activation by C-reactive protein
HATTORI, Y., MATSUMURA, M., & KASAI, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00855-6 · Cited by 217
Rueckschloss, U., Quinn, M. T., Holtz, J., & Morawietz, H. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000035392.38687.65 · Cited by 216
Antioxidants and Atherosclerosis: Don’t Throw Out the Baby With the Bath Water
Jialal, I., & Devaraj, S. (2003) · Circulation · doi:10.1161/01.cir.0000048966.26216.4c · Cited by 208
Self-citationVitamin C and risk of coronary heart disease in women
Osganian, S. K., Stampfer, M. J., Rimm, E., Spiegelman, D., Hu, F. B., Manson, J. E., & Willett, W. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00575-8 · Cited by 208
Detmers, P. A., Hernandez, M., Mudgett, J., Hassing, H., Burton, C., Mundt, S., Chun, S., Fletcher, D., Card, D. J., Lisnock, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3430 · Cited by 207
Hyperhomocysteinemia and its role in the development of atherosclerosis
Lawrence de Koning, A. B., Werstuck, G. H., Zhou, J., & Austin, R. C. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00062-6 · Cited by 205
Oxidized low density lipoprotein and innate immune receptors
Miller, Y. I., Chang, M.-K., Binder, C. J., Shaw, P. X., & Witztum, J. L. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00004 · Cited by 201
Channon, K. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.10.003 · Cited by 196
Gniwotta, C., Morrow, J. D., Roberts, L. J., & Kühn, H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3236 · Cited by 196
Strategies to reduce oxidative stress in cardiovascular disease
HAMILTON, C. A., MILLER, W. H., AL-BENNA, S., Julia BROSNAN, M., DRUMMOND, R. D., McBRIDE, M. W., & DOMINICZAK, A. F. (2004) · Clinical Science · doi:10.1042/cs20030379 · Cited by 190
Parinandi, N. L., Kleinberg, M. A., Usatyuk, P. V., Cummings, R. J., Pennathur, A., Cardounel, A. J., Zweier, J. L., Garcia, J. G. N., & Natarajan, V. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00123.2002 · Cited by 190
Bayraktutan, U. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00003-0 · Cited by 188
C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells
Venugopal, S. K., Devaraj, S., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000094736.10595.a1 · Cited by 184
Self-citationProducts of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation
Roberts, L. J., & Morrow, J. D. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8469-8 · Cited by 182
Mertens, A., Verhamme, P., Bielicki, J. K., Phillips, M. C., Quarck, R., Verreth, W., Stengel, D., Ninio, E., Navab, M., Mackness, B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000056523.08033.9f · Cited by 172
Formation of Dysfunctional High-Density Lipoprotein by Myeloperoxidase
Nicholls, S. J., Zheng, L., & Hazen, S. L. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.06.004 · Cited by 171
Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice
McMillen, T. S., Heinecke, J. W., & LeBoeuf, R. C. (2005) · Circulation · doi:10.1161/circulationaha.104.516278 · Cited by 167
Zou, M.-H., Leist, M., & Ullrich, V. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65390-4 · Cited by 163
Hsich, E., Segal, B. H., Pagano, P. J., Rey, F. E., Paigen, B., Deleonardis, J., Hoyt, R. F., Holland, S. M., & Finkel, T. (2000) · Circulation · doi:10.1161/01.cir.101.11.1234 · Cited by 158
l -Arginine Prevents Xanthoma Development and Inhibits Atherosclerosis in LDL Receptor Knockout Mice
Aji, W., Stefano Ravalli, A., Szabolcs, M. J., Jiang, X.-C., Sciacca, R. R., Michler, R. E., & Cannon, P. (1997) · Circulation · doi:10.1161/01.cir.95.2.430 · Cited by 156
Reddy, M. A., Thimmalapura, P., Lanting, L. L., Nadler, J. L., Fatima, S., & Natarajan, R. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111305200 · Cited by 135
Qamirani, E., Ren, Y., Kuo, L., & Hein, T. W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000159890.10526.1e · Cited by 133
Bevers, L. M., Braam, B. G., Post, J. A., van Zonneveld, A. J., Rabelink, T. J., Koomans, H. A., Verhaar, M. C., & Joles, J. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000196735.85398.0e · Cited by 132
Exacerbated Transplant Arteriosclerosis in Inducible Nitric Oxide–Deficient Mice
Koglin, J., Glysing-Jensen, T., Mudgett, J. S., & Russell, M. E. (1998) · Circulation · doi:10.1161/01.cir.97.20.2059 · Cited by 128
Altered Tetrahydrobiopterin Metabolism in Atherosclerosis
Vasquez-Vivar, J. M., Duquaine, D. C., Whitsett, J., Kalyanaraman, B., & Rajagopalan, S. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000029122.79665.d9 · Cited by 123
Stokes, K. Y., Clanton, E. C., Russell, J. M., Ross, C. R., & Granger, D. N. (2001) · Circulation Research · doi:10.1161/01.res.88.5.499 · Cited by 114
Aging, smooth muscle cells and vascular pathobiology: Implications for atherosclerosis
Orlandi, A., Bochaton‐Piallat, M., Gabbiani, G., & Spagnoli, L. G. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.018 · Cited by 111
Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques.
Penn, A. L., & Snyder, C. A. (1993) · Circulation · doi:10.1161/01.cir.88.4.1820 · Cited by 101
NADPH Oxidase in Endothelial Cells: Impact on Atherosclerosis
Rueckschloss, U., Duerrschmidt, N., & Morawietz, H. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603764816532 · Cited by 100
Chen, J., Kuhlencordt, P., Urano, F., Ichinose, H., Astern, J., & Huang, P. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040223.74255.5a · Cited by 96
Gordon, L. B., Harten, I. A., Patti, M., & Lichtenstein, A. H. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.10.064 · Cited by 90
Zhang, C., Yang, J., Jacobs, J. D., & Jennings, L. K. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00435.2003 · Cited by 86
Determinants of F2-isoprostane biosynthesis and inhibition in man
Davì, G., Falco, A., & Patrono, C. (2003) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.10.001 · Cited by 85
α-Tocopherol and Atherosclerosis
Kaul, N., Devaraj, S., & Jialal, I. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122600102 · Cited by 85
Self-citationMeininger, C. J., Cai, S., Parker, J. L., Channon, K. M., Kelly, K. A., Becker, E. J., Wood, M., Wade, L. A., & Wu, G. (2004) · The FASEB Journal · doi:10.1096/fj.04-1702fje · Cited by 81
Behr‐Roussel, D., Rupin, A., Simonet, S., et al. (2000) · Circulation · doi:10.1161/01.cir.102.9.1033 · Cited by 78
Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats
Nozawa, K., Tuck, M. L., Golub, M. S., Eggena, P., Nadler, J. L., & Stern, N. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.6.h1774 · Cited by 73
de Souza, H. P., Laurindo, F. R. M., Ziegelstein, R. C., Berlowitz, C. O., & Zweier, J. L. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.2.h658 · Cited by 73
Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein
Jialal, I. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1827 · Cited by 72
Self-citationNIDDM is associated with lower wall shear stress of the common carotid artery.
Irace, C., Carallo, C., Crescenzo, A., Motti, C., Franceschi, M. S. D., Mattioli, P. L., & Gnasso, A. (1999) · Diabetes · doi:10.2337/diabetes.48.1.193 · Cited by 70
Gu, J., Pei, H., Thomas, L. S., Nadler, J. L., Rossi, J. J., Lanting, L. L., & Natarajan, R. D. (2001) · Circulation · doi:10.1161/01.cir.103.10.1446 · Cited by 65
Bagi, Z. A., Ungvari, Z. I., & Koller, Á. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101127 · Cited by 64
Impaired Nitric Oxide-Mediated Flow-Induced Coronary Dilation in Hyperhomocysteinemia
Ungvari, Z. I., Csiszár, A., Bagi, Z. A., & Koller, Á. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64166-1 · Cited by 60
Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia
Delgado‐Esteban, M., Almeida, Á., & Medina, J. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01055.x · Cited by 58
Ungvari, Z. I., Sarkadi‐Nagy, E., Bagi, Z. A., Szollár, L. G., & Koller, Á. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1203 · Cited by 57
Pandolfi, A., Grilli, A., Cilli, C., Patruno, A., Giaccari, A., Silvestre, S. D., Lutiis, M. A. D., Pellegrini, G., Capani, F., Consoli, A., et al. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10325 · Cited by 55
Oxidative Stress and the Vascular Wall
Keaney, J. F. (2005) · Circulation · doi:10.1161/circulationaha.105.578146 · Cited by 55
Kukovetz, E. M., Bratschitsch, G., Hofer, H. P., Egger, G., & Schaur, R. J. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00334-6 · Cited by 55
NOS2 Mediates Opposing Effects in Models of Acute and Chronic Cardiac Rejection
Koglin, J., Glysing-Jensen, T., Mudgett, J. S., & Russell, M. E. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65723-9 · Cited by 49
Reddy, M. A., Kim, Y., Lanting, L. L., & Natarajan, R. D. (2003) · Hypertension · doi:10.1161/01.hyp.0000069011.18333.08 · Cited by 49
Carr, A. C., & Frei, B. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009082200 · Cited by 46
Renin???Angiotensin System as a Therapeutic Target in Managing Atherosclerosis
Ferrario, C. M., Richmond, R. S., Smith, R. D., et al. (2004) · American Journal of Therapeutics · doi:10.1097/00045391-200401000-00010 · Cited by 44
The Oxidative Paradox: Another Piece in the Puzzle
Patterson, C., Madamanchi, N. R., & Runge, M. S. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1074 · Cited by 42
The role of lipoxygenase-isoforms in atherogenesis
Kühn, H., Römisch, I., & Belkner, J. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500131 · Cited by 41
Ou, X., & Ramos, K. S. (1992) · Toxicology · doi:10.1016/0300-483x(92)90143-3 · Cited by 36
Ramos, K. S., Zhang, Y., Sadhu, D. N., & Chapkin, R. S. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0335 · Cited by 36
C-Reactive Protein Augments Interleukin-8 Secretion in Human Peripheral Blood Monocytes
Xie, L., Chang, L., Guan, Y., & Wang, X. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000183568.48389.a1 · Cited by 32
Frei, B. B. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00574-6 · Cited by 29
Sepiapterin Treatment in Atherosclerosis
Tarpey, M. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000038144.37823.bf · Cited by 27
Murthy, K. G. K., Szab�, C., & Salzman, A. L. (2004) · Inflammation Research · doi:10.1007/s00011-004-1301-1 · Cited by 6
Possible Impact of Tetrahydrobiopterin and Sepiapterin on Endothelial Dysfunction
Blau, N., & Thöny, B. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000068647.92130.0d · Cited by 4
Cited by
Review on in vivo and in vitro methods evaluation of antioxidant activity
Alam, M. N., Bristi, N. J., & Rafiquzzaman, M. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.05.002 · Cited by 1,758
Chronic Inflammatory Diseases and Endothelial Dysfunction
Castellon, X., & Bogdanova, V. (2016) · Aging and disease · doi:10.14336/ad.2015.0803 · Cited by 191
Verit, F. F., Erel, O., & Celik, N. (2007) · Human Reproduction · doi:10.1093/humrep/dem340 · Cited by 115
Metadata
- Authors
- Singh, U., & Jialal, I.
- Venue
- Pathophysiology
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 13
- Issue
- 3
- Pages
- 129-142
- ISSN
- 0928-4680 (ISSN-L)
- OpenAlex
- W2059350161
- Cited by
- 490
- References
- 131
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.